Navigation Links
Vermillion Reports Financial Results for the First Quarter 2011
Date:5/10/2011

the Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.
  • Commenced enrollment of subjects in the PAD intended use study being performed in collaboration with the Colorado Prevention Center. The study remains on track to result in top-line data during the third quarter of 2011.
  • Strengthened our balance sheet by completing an underwritten follow-on public offering of our common stock, resulting in approximately $20.2 million net proceeds to the Company.

  • "We continued to make progress in multiple areas during the first quarter.  We grew OVA1 sales as well as had several presentations highlighting the benefit of OVA1 as an aid for physicians in the assessment of adnexal masses.  On the clinical development front, our PAD and OVA2 programs moved forward and remain on track to generate data later this year.  We also strengthened our balance sheet, which affords us the flexibility to help accelerate our current initiatives as well as opportunistically act on potential new growth drivers," said Gail S. Page, Chair of the Board of Directors and CEO.

    For the second quarter of 2011, we expect 3,200 to 3,500 OVA1 tests to be performed.  This forward guidance takes into consideration numerous factors including the number of days in the quarter, continued limited coverage by the larger payers, and the ability to expand the number of diagnosis codes currently approved by Medicare.

    Total revenues for the first quarter of 2011 were $431,000 compared to $73,000 for the first quarter of 2010.  Revenues for the first quarter of 2011 included $317,000 from product sales of OVA1 and $114,000 of license revenue related to the Company's achievement of certain milestones under the Strategic Alliance Agreement with Quest Diagnostics.  As of March 31, 2011, the Company's cash and short-term investments totaled $40.2
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vermillion Receives Award From the Society of Gynecologic Oncologists
    2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
    4. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
    5. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
    6. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
    7. Vermillion Announces the Reappointment of Officers and Confirmation of Director
    8. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
    9. Vermillion Announces $43.05 Million Private Placement of Common Stock
    10. Vermillion Files Plan of Reorganization
    11. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... MILPITAS, Calif. , July 10, 2014 ... a leader in advanced memory and analog IC solutions, ... call on Thursday, July 24, 2014, at 7:00 a.m. ... Company,s financial results for the fiscal 2014 third quarter ... conference call via telephone, dial 1-888-556-4997 before 6:50 a.m. ...
    (Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
    (Date:1/15/2014)... 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced sales ... compared to sales of $2,202,000 for the prior year period, ... has also shown growth over the preceding quarter,s sales, continuing ... fiscal year. Markets that experienced sales increases over the prior ...
    Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
    ... Volcano Corporation (Nasdaq: VOLC ) announced today the completion of the first ... performed in seven centers within the United States . Commercial launch of Eagle ... , , ... , , ...
    ... , SAN DIEGO , May 20 ... announced today that the U.S. Patent and Trademark Office has ... microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell Separation ... to isolate cells from a bodily fluid using a flow ...
    Cached Medicine Technology:Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 2Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 3Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 4Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology 2
    (Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
    (Date:7/12/2014)... July 12, 2014 Utah Valley Entrepreneurial ... startups, with awards being bestowed to companies in revenue, ... outstanding entrepreneur community with recognition for new ideas as ... with incoming revenue. , 25 Under 5 highlights outstanding ... that are under 5 years old. Award recipients were ...
    (Date:7/12/2014)... Texas (PRWEB) July 12, 2014 ... Breastfeeding Made Simple as a valuable new resource for ... roughly two-thirds of American women work away from their ... sources touting the benefits of breastfeeding, but often feel ... to nurse their babies. With its evidence-based insights, and ...
    (Date:7/12/2014)... CA (PRWEB) July 12, 2014 ... power score of 4.1 out of 5. This ... that have been underpinning buyer negotiation power over ... procurement analyst Anna Son, “during the period, surging ... rising costs associated with new product development, have ...
    (Date:7/12/2014)... Ladies, it doesn't matter what your budget is, ... looking for an affordable gown can visit Discount-Dress.com ... get their dream items. Recently, the company has announced its ... Along with that, it is also providing great discounts for ... the deadline of this promotion is July 29, 2014. ...
    Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2
    ... YORK (June 15, 2011) -- Ever since the Institute of ... 1999, significant attention has been paid to improving patient safety ... events, including major injury and even death, occur in private ... study -- the first of its kind -- researchers at ...
    ... , TUESDAY, June 14 (HealthDay News) -- Patients ... if they have elevated levels of a certain hormone, a ... (FGF-23) regulates phosphorus metabolism. It was known that levels of ... of the hormone are associated with increased risk of death ...
    ... where open space is plentiful and there is often ... rural elders are far more likely to be overweight ... suburban counterparts, according to a new policy brief from ... All three conditions are risk factors for heart ...
    ... growth is blocked by drugs targeting that path, the malignancy ... around the roadblock. In a study at UCLA,s Jonsson ... of prostate cancer was treated with conventional hormone ablation therapy ... growth of the tumor the cancer was able to ...
    ... Day this Sunday is a chance to recognize dads for putting ... up on the way to adulthood. But a new study ... dad,s job as a role model actually is. The study, ... and Environmentally Controlled Sibling Study," is due to be published in ...
    ... By Jenifer Goodwin HealthDay Reporter , TUESDAY, June ... they might also sleep better, according to researchers who say ... sleeptime, may help treat insomnia. Previous research has shown ... have a higher brain metabolism in the frontal lobes, which ...
    Cached Medicine News:Health News:JAMA study points to patient safety risks outside hospital walls 2Health News:JAMA study points to patient safety risks outside hospital walls 3Health News:Hormone Linked to Death Risk in Those With Early Kidney Disease 2Health News:Out of reach? Rural elders have highest rates of obesity, diabetes, heart disease 2Health News:Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway 2Health News:Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway 3Health News:Note to dads: Good parenting makes a difference 2Health News:Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds 2Health News:Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds 3
    The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
    ... design of the osteotomy staples is quite similar to ... are the inner position of the anti recoil contours ... staples). There are 3 kinds of staples: ... and the staples can have 3 different widths: 20mm, ...
    A new generation of ORTHOMED S.A. fixation staples, manufactured from cobalt-chromium alloy: tried and test strength and tolerance...
    ... Sterile Barium Sulfate USP is specifically ... consistent imaging capabilities for todays medical ... minimally invasive surgery. Comprised of a ... even diffusion of sterile barium, resulting ...
    Medicine Products: